Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

5.840 -0.090 (-1.52%)

Delayed Quote Updated: 10:40 AM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Capricor Therapeutics, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings ↗

September 29, 2023

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 1% on Friday. The Dow traded up 0.24% to 33,746.70 while the NASDAQ rose 1.22% to 13,362.51. The S&P 500 also rose,...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 29, 2023

Via Benzinga

Top 5 Health Care Stocks That May Fall Off A Cliff ↗

August 23, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Recap: Capricor Therapeutics Q1 Earnings ↗

May 11, 2023

Via Benzinga

Earnings Preview For Capricor Therapeutics ↗

March 14, 2023

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

Earnings Scheduled For March 15, 2023 ↗

March 15, 2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.

Via Benzinga

Capricor Highlights Preclinical Data From Its Closed COVID-19 Vaccine Study ↗

January 12, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022 ↗

October 26, 2022

Upgrades

Via Benzinga

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary ↗

July 19, 2022

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness...

Via Benzinga

Capricor Initiates Late-Stage Neuropsychiatric Disorder Study ↗

July 19, 2022

Capricor Therapeutics (NASDAQ: CAPR) initiated dosing of first patient in HOPE-3, a Phase 3 clinical trial investigating CAP-1002 for treating late-stage Duchenne muscular dystrophy (DMD).

Via Benzinga

More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying ↗

July 08, 2022

U.S. stock futures traded lower this morning on Friday ahead of jobs report for june. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

7 Undervalued Penny Stocks With Major Upside ↗

March 29, 2022

Each of these penny stocks has proven momentum throughout 2022 and major upside on top of the returns through the the first quarter.

Via InvestorPlace

Mid-Afternoon Market Update: Dow Drops 150 Points; Capricor Therapeutics Shares Plunge ↗

March 28, 2022

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 150 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 28, 2022

Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 38.3% to $1.66 during Monday's regular session. The current volume of 3.5 million shares is 142.9% of TC...

Via Benzinga

50 Biggest Movers From Yesterday ↗

March 29, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

March 28, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron....

Via Benzinga

Capricor Shares Fall After Topline Results From Mid-Stage COVID-19 Trial ↗

March 28, 2022

Capricor Therapeutics Inc (NASDAQ: CAPR) announced topline data from its Phase 2 INSPIRE study evaluating a single-dose intravenous infusion of CAP-1002 for hospitalized COVID-19 patients.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 28, 2022

Gainers OncoSec Medical (NASDAQ:ONCS) shares moved upwards by 27.1% to $1.5 during Monday's pre-market session. The company's market cap stands at $59.0 million....

Via Benzinga

Capricor Stops Work On Exosome-mRNA Based COVID-19 Vaccine Candidate ↗

March 11, 2022

In its Q4 FY21 earnings press release, Capricor Therapeutics Inc (NASDAQ: CAPR) said it had halted work on the exosome-based jab due to the "current...

Via Benzinga

Capricor Therapeutics: Q4 Earnings Insights ↗

March 10, 2022

Capricor Therapeutics (NASDAQ:CAPR) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Earnings Outlook For Capricor Therapeutics ↗

March 09, 2022

Capricor Therapeutics (NASDAQ:CAPR) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement....

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 03, 2022

Gainers SOC Telemed (NASDAQ:TLMD) shares increased by 333.5% to $2.79 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 19.4...

Via Benzinga

51 Biggest Movers From Yesterday ↗

January 26, 2022

Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients...

Via Benzinga

28 Stocks Moving In Tuesday's Mid-Day Session ↗

January 25, 2022

Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares jumped 47.8% to $22.93 after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic,...

Via Benzinga

Capricor Therapeutics, Nippon Shinyaku Ink US Pact For Duchenne Muscular Dystrophy Candidate ↗

January 25, 2022

Capricor Therapeutics Inc (NASDAQ: CAPR) has partnered with Nippon Shinyaku Co Ltd for the exclusive commercialization and distribution in the U.S of Capricor...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data ↗

January 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate Pfizer,...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

October 11, 2021

Keybanc lifted Netflix, Inc. (NASDAQ: NFLX) price target from $645 to $670. Netflix shares rose 0.1% to $633.00 in pre-market trading. JMP Securities raised ServiceNow, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.